The clinical experience implies poor prognosis in women with myocardial infarction (MI). We performed a retrospective cohort study of 1395 patients - 987 (70,75%) men and 408 (29,25%) women) aged of 64,63±11,43 years with myocardial infarction and comorbidity hospitalized between 2010-2016. This study shows an increase of mortality in women with myocardial infarction during the last 4 years from 23,1% to 34,2%. We observed more frequent cases of non-STEMI (p=0,014) and recurrent myocardial infarction in females compared with males (р<0,0001). Arterial hypertension with elevated diastolic pressure was more common women than in men (86,4% vs 68,7%, p=0,0001). Being overweight (p<0,0001), abdominal obesity (p=0,019), hypercholesterolemia, elevated low-density lipoprotein (p=0,005) were more common in females than in males. Type 2 diabetes mellitus was more frequent in women (32,6% compared with men 20,1%), the duration of the disease was also longer in females 10,3±0,8 years vs 7,3±0,5 years in men. Thyroid problems were observed more often in male (р<0,0001). Gastrointestinal ulcer was more common in men - 10,6% vs 6,6% compared with woman, p=0,019, while the bile duct diseases were more frequent in women - 8,3% vs 3,9 % compared with men, p=0,003. The mortality rate in acute myocardial infarction was 1.5-fold more frequent in women and due to age, heart rate, oxygen saturation at first day of myocardial infarction, NYHA functional class, left ventricular end-diastolic dimension index. The survival analyses after myocardial infarction was performed with the Kaplan-Meier method. It showed higher mortality level in females (χ2=26,73; р<0,0001).

Download full-text PDF

Source

Publication Analysis

Top Keywords

myocardial infarction
20
women myocardial
8
myocardial
5
infarction
5
[the local
4
local registry
4
registry data
4
data myocardial
4
women
4
infarction women
4

Similar Publications

The autonomic nervous system plays a crucial role in regulating physiological processes and maintaining homeostasis through its two branches: the sympathetic nervous system (SNS) and the parasympathetic nervous system. Dysregulation of the autonomic system, characterized by increased sympathetic activity and reduced parasympathetic tone, is a common feature in chronic kidney disease (CKD) and cardiovascular disease. This imbalance contributes to a pro-inflammatory state, exacerbating disease progression and increasing the risk for cardiovascular events.

View Article and Find Full Text PDF

Introduction: The infarcted heart is energetically compromised exhibiting a deficient production of adenosine triphosphate (ATP) and the ensuing impaired contractile function. Short-term blockade of the protein S100A9 improves cardiac performance in mice after myocardial infarction (MI). The implications upon ATP production during this process are not known.

View Article and Find Full Text PDF

Rationale: The biodegradable polymer BioMatrix Alpha™ stent contains biolimus A9 drug which is sirolimus derivative increase in lipophicity. The biodegradable polymer sirolimus eluting Combo™ stent is a dual-therapy sirolimus-eluting and CD34+ antobody coated stent capturing endothelial progenitor cells (EPCs).

Hypothesis: The main hypothesis of the SORT OUT XI trial was that the biodegradable polymer biolimus A9 BioMatrix Alpha ™ stent is noninferior to the biodegradable polymer sirolimus eluting Combo™ stent in an all-comers population with coronary artery disease undergoing percutaneous coronary intervention (PCI).

View Article and Find Full Text PDF

Background: Despite the high mortality of cardiogenic shock after acute myocardial infarction (AMI-CS), the comparative efficacy and safety of mechanical circulatory support (MCS) in patients with AMI-CS is unknown. This study aimed to compare the efficacy and safety of various MCS with initial medical therapy for AMI-CS patients.

Methods: We searched PubMed and EMBASE in July 2024.

View Article and Find Full Text PDF

Background - Although Factor XI (FXI) inhibitors are currently tested for the prevention of thrombotic events, their early treatment could prevent thrombus consolidation in ST-segment elevation myocardial infarction (STEMI). This study aims to characterize coagulation FXI levels and their variations in patients with STEMI undergoing primary percutaneous coronary intervention (PCI). Methods - Patients with STEMI were prospectively enrolled between December 2023 and May 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!